Human Vaccines & Immunotherapeutics

雜志介紹

Human Vaccines & Immunotherapeutics雜志介紹

《Human Vaccines & Immunotherapeutics》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)人類(lèi)疫苗和免疫療法，本刊主要出版、報(bào)道醫(yī)學(xué)-BIOTECHNOLOGY & APPLIED MICROBIOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為4.1，最新CiteScore 指數(shù)為7.9。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients

  Author: Chen, Sikai; Wei, Wenxin; Huang, Fengyu; Wang, Jing; Li, Xingyu; Gen, Zhixin; Gao, Feng; Dong, Taiwei; Wei, Peifeng; Yang, Xinbo; Miao, Feng

• Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial

  Author: Sun, Dapeng; Yu, Dan; Du, Zhenhua; Jia, Ningning; Liu, Xiaodong; Sun, Jianwen; Xu, Qing; Sun, Zhuoqun; Luan, Chunfang; Lv, Jingjing; Xiong, Ping; Zhang, Li; Sha, Xueyan; Gao, Yongjun; Kang, Dianmin

• Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China

  Author: Yin, Zhiying; Fang, Quanjun; Wen, Tingcui; Zheng, Canjie; Fu, Canya; Wang, Shuangqing; Li, Junji; Gong, Xiaoying

• Establishment of the 1st Chinese national standard for CA6 neutralizing antibody

  Author: Wang, Yiping; Gao, Fan; Liang, Zhenglun; Sun, Huimin; Wang, Junzhi; Mao, Qunying

英文介紹

Human Vaccines & Immunotherapeutics雜志英文介紹

(formerly Human Vaccines; issn 1554-8619)

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.